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Abstract. In mature neurons, tau is abundant in axons, 
whereas microtubule-associated protein 2 (MAP2) and 
MAP2C are specifically localized in dendrites. Known 
mechanisms involved in the compartmentalization of 
these cytoskeletal proteins include the differential lo- 
calization of mRNA (MAP2 mRNA in dendrites, 
MAP2C mRNA in cell body, and Tau mRNA in proxi- 
mal axon revealed by in situ hybridization) (Garner, C.C., 
R.P. Tucker, and A. Matus. 1988. Nature (Lond.). 336: 
674--677; Litman, P., J. Barg, L. Rindzooski, and I. Ginz- 
burg. 1993. Neuron. 10:627-638), suppressed transit of 
MAP2 into axons (revealed by cDNA transfection into 
neurons) (Kanai, Y., and N. Hirokawa. 1995. Neuron. 
14:421-432), and differential turnover of MAP2 in ax- 
ons vs dendrites (Okabe, S., and N. Hirokawa. 1989. 
Proc. Natl. Acad. Sci. USA. 86:4127-4131). To investi- 
gate whether differential turnover of MAPs contributes 
to localization of other major MAPs in general, we mi- 
croinjected biotinylated tau, MAP2C, or MAP2 into 
mature spinal cord neurons in culture (~3 wk) and then 
analyzed their fates by antibiotin immunocytochemis- 
try. Initially, each was detected in axons and dendrites, 
although tau persisted only in axons, whereas MAP2C 
and MAP2 were restricted to cell bodies and dendrites. 
Injected MAP2C and MAP2 bound to dendritic micro- 
tubules more firmly than to microtubules in axons, 
while injected tau bound to axonal microtubules more 
firmly than to microtubules in dendrites. Thus, beyond 
contributions from mRNA localization and selective 
axonal transport, compartmentalization of each of the 
three major MAPs occurs through local differential 
turnover. 
IFFERENT compartmentalization of the cytoskeletal 
elements in nerve cells is an important feature oc- 
curring in the highly polarized structural differen- 
tiation shown by dendrites and axons of these cells (Dotti 
and  Banker,  1987; Cleveland,  1990; Hirokawa,  1994). 
Among the cytoskeletal proteins showing a polarized dis- 
tribution, microtubule-associated protein 2 (MAP2)  1 is spe- 
cifically  localized  in  dendrites  (Bernhardt  and  Matus, 
1984; Caceres et al., 1984; Cumming et al., 1994; De Cam- 
illi et al., 1984), while tau is abundant in axons (Binder et 
al., 1985; Kosik and Finch, 1987; Peng et al., 1986; Brion et 
al., 1988; Mandell and Banker, 1995). Furthermore, MAP2C, 
an isoform derived from the MAP2  gene by alternative 
splicing, is specifically localized in both axons and den- 
drites in juvenile neurons (Tucker et al., 1988a; Meichsner 
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1. Abbreviations used in this paper. MAP, microtubule-associated protein; 
MT, microtubule; RT, room temperature. 
et al., 1993), whereas it is no longer present in axons in ma- 
ture neurons (Tucker et al., 1988b). Recent molecular bio- 
logical approaches  have revealed that cDNAs  of MAP2 
(1828  amino acids), MAP2C (467  amino acids), and tau 
(432 amino acids) are composed of an NH2-terminal pro- 
jection domain having different lengths, with homologous 
microtubule-binding domains consisting of three to  four 
repeats of 18 amino acids being located at the COOH-ter- 
minal region (reviewed by Goedert et al., 1991). Moreover, 
when MAP2 and tau are expressed in nonneuronal cells, 
these  cells  grow  thin  processes  in  which  microtubules 
(MT) form bundles (Kanai et al., 1989; Lewis et al., 1989; 
Knops et al., 1991). In fact, MT bundles resembling those 
found in dendrites and axons are formed in the thin pro- 
cesses induced by expression of MAP2  and tau, respec- 
tively (Knops et al.,  1991; Chen et al., 1992).  Our recent 
gene targeting study of tau protein  indicated its impor- 
tance in the organization and stabilization of MTs in small 
caliber axons and also suggested that several MAPs may 
play a  group role in affecting their functions (Harada et 
al., 1994). Hence, the polarized distribution of MAPs may 
have an important relationship with neuronal morphogen- 
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this polarized distribution of MAP2, MAP2C, and tau is of 
major importance,  since  they may not  only be involved 
with neurons in general, but also with other cells that com- 
partmentalize cytoskeletal proteins. 
In terms of the mechanism for this compartmentaliza- 
tion  of  MAPs,  evidence  has  been  presented  for  three 
mechanisms (see Fig.  1).  The first is differential localiza- 
tion of mRNA. In situ hybridization studies have indicated 
that MAP2 and tau mRNAs extend into dendrites and ax- 
ons, respectively, while MAP2C mRNA is confined to cell 
bodies  (Garner et  al.,  1988;  Litman et  al.,  1993).  These 
studies  have  proposed  that  differential  localization  of 
mRNA results in the final localization of MAPs. 
The  second  mechanism  demonstrated  is  differential 
turnover of MAP2  in the  axon vs in  the  dendrites.  This 
possibility arose from the microinjection of biotin-labeled 
MAP2 into cultured mature spinal cord neurons and sub- 
sequent  analysis of the localization of injected MAP2 in 
the axon and dendrites (Okabe and Hirokawa, 1989).  This 
study indicated  that injected  MAP2  is conveyed to both 
dendrites  and the axon after 1 d, but MAP2 in the axon 
turned over quickly and disappeared ~3-4 d  after micro- 
injection, while MAP2 is stabilized in dendrites °°3-4 d af- 
ter microinjection. 
The third mechanism is the suppressed transit into ax- 
ons. This was shown for MAP2 by transfection of a cDNA 
encoding it into cultured spinal cord neurons (Kanai and 
Hirokawa, 1995).  Although  tau and MAP2C were trans- 
ported into the axon, MAP2 was not. 
Although  all three mechanisms are apparently used to 
localize MAP2, the relative contribution of each for two of 
the known MAPs, tau and MAP2C, is lacking. No earlier 
efforts have examined the potential that differential turn- 
over of these  in  axons  and  dendrites  may contribute  to 
compartmentalization.  In the case of MAP2C,  mRNA is 
confined to the cell body (Garner et al., 1988)  and despite 
its transport of the protein into the axon (Kanai and Hi- 
rokawa, 1995), MAP2C is compartmentalized in cell bod- 
ies  and  dendrites  in  matured  neurons  (Tucker  et  al., 
1988b). This strongly suggests that compartmentalization 
of MAP2C  requires  differential  stabilization  in  the  cell 
body and dendrites. 
To test this and to extend the analysis of differential sta- 
bility to tau, we have microinjected biotin-labeled tau, bi- 
otin-MAP2C,  and  biotin-MAP2  into  the  mature  spinal 
cord neurons, and subsequent analyses of the fates of in- 
jected MAPs at light microscopic and electron microscopic 
levels were performed. 
Materials and Methods 
Preparation of Biotin-labeled Proteins 
Porcine brain MTs were prepared by temperature-dependent assembly 
and disassembly (Shelanski et  al.,  1973). MT proteins were conjugated 
with N-hydroxy-succinimidyl biotin (Kristofferson et al., 1986; Okabe and 
Hirokawa, 1989). Briefly,  we heated 500 mg of MT proteins in 100 ml of 
assembly buffer (25% (vol/vol) glycerol, 100 mM Pipes, 1 mM MgC12, 1 mM 
EGTA, pH 6.8) containing 1 mM ATP and 10 mg/ml leupeptin at 37°C for 
5 min and then added  100 mg of N-hydroxy-succinimidyl biotin.  The bi- 
otin labeling  was allowed to proceed for 15 rain, after which the reaction 
was quenched by adding  1 g of potassium glutamate. The labeled MTs 
were further purified by two assembly--disassembly  cycles. Biotin-tau and 
-MAP2 were separated from MTs by a method described previously (Hi- 
rokawa et al., 1988a, b). MAP2C was purified from porcine brain accord- 
ing to Takeuchi et al. (1992). Purified MAP2C was incubated with tubulin 
purified from porcine brains by phosphocellulose column chromatogra- 
phy in one-third vol glycerol  in PEM (0.1 M Pipes, 1 mM EGTA, 1 mM 
MgCI2, pH 6.8) at 37°C for 30 min. The resultant MT proteins were la- 
beled with N-hydroxy-succinimidyl biotin as described above. After the 
reaction was quenched by K-glutamate, the MT proteins were centrifuged 
at 38,000 rpm (L8-8M Ultracentrifuge;  Beckman Instruments, Inc., Fullerton, 
CA) at 35°C for 30 min. The pellets were suspended in 1 M NaCI-PEM at 
4°C for 40 min, which was then applied to a PD10 column (Pharmacia Bio- 
tech AB, Uppsala, Sweden) to remove tubulin. The flow-through was col- 
lected and centrifuged at 2°C for 10 rain. After adding 2 mM DTT, the su- 
pernatant was boiled for 5 min, immediately cooled on ice for 30 min, and 
then brought to 50% saturation in ammonium sulfate by the addition of 
saturated ammonium sulfate.  The sample was stirred for 30 min at 4°C 
and centrifuged at 12,000 g for 20 rain at 4°C to precipitate  biotin-labeled 
MAP2C.  The precipitate  was suspended in PEM buffer containing 0.75 M 
NaCI and then dialyzed  against PEM. 
Binding of Biotin-labeled Proteins to MT 
Tan, biotin-tau, MAP2, biotin-MAP2, MAP2C, biotin-MAP2C, and tubu- 
lin in PEM buffer were centrifuged (TL 100; Beckman Instruments, Inc.) 
at 55,000 rpm for 30 rain at 2°C. The supernatants were used for the exper- 
iments. All of these MAPs were mixed with tubulin (concentrations of 
MAPs and tubulin were 1.5 and 2 mg/ml, respectively) and incubated at 
37°C for 30 rain in the presence of 1 mM GTP. Then they were again cen- 
trifuged at 55,000 rpm for 30 min at 35°C. Supernatants and pellets were 
separated, and the pellets were suspended in PEM of equal volume to the 
supernatant. The same volume of supernatants and  pellets was subse- 
quently analyzed by SDS-PAGE. 
Cell Culture and Microinjection 
Spinal cord neurons of mouse embryos were cultured according to the 
method of Ranson et al.  (1977).  Mature neurons (~3-wk culture) were 
used. PC12 cells were cultured and fused using polyethylene glycol as de- 
scribed previously (Okabe and Hirokawa, 1988). Microinjection was per- 
formed according to Graessmann et  al.  (1980).  For microinjection, the 
stored sample was dialyzed  and diluted with an injection buffer (50 mM 
potassium glutamate, 1 mM MgC12, pH 6.8)  to 2-2.3 mg/ml. Cells  were 
placed on a Diaphot inverted microscope (Nikon Inc., Garden City, NY) 
and then pressure injected  using a micromanipulator (Narishige Scientific 
Laboratory, Tokyo, Japan). During the injection procedure, the cells were 
videotaped with a time-lapse videotape recorder to determine the exact 
incubation  time  after  injection.  The  volume injected  per cell  was esti- 
mated by the method of Graessmann et al. (1980). Under a constant flow 
rate of the sample solution, we recorded the meniscus movement within 
the pipette and determined the sample solution flow rate. Using this flow 
rate and the mean injection time per cell, the volume injected per cell was 
estimated at <10  -l° ml. Because the cell body of the smallest cell used was 
~30 mm in diameter and mostly hemispheric in shape, and because the 
height of the cell body was ~5 mm, the calculated  volume of this cell body 
was ~2.4 ×  10 -9 ml. From these data, the injected  volume was estimated 
at <4.2% of the cell body volume. 
Immunofluorescence Localization and 
Immunoblotting of Native Tau, MAP2, and MAP2C in 
Spinal Cord Neurons in Culture 
Cultured neurons (~3-wk culture) were fixed with 2% paraformaldehyde 
and 0.1%  glutaraldehyde in PEM buffer for 30 min at room temperature 
(RT). After washing with PBS, they were permeabilized by immersion in 
100% methanol at -20°C for 6 min. Next, they were washed with PBS and 
incubated with 5% skim milk in PBS containing 10%  normal goat serum 
for 30 min at 35°C. As the first antibodies, we used 100-fold diluted affin- 
ity-purified  anti-MAP2 rabbit IgG (Hirokawa et al.,  1988b) and 50-fold 
diluted anti-tau mouse mAb Tau-1  (Binder et al.,  1985). In some cases, 
anti-MAP2 mouse mAb (HM-2; Sigma Chemical Co., St. Louis, MO) was 
used as the first antibody. The cells were stained with these first antibod- 
ies for 1 h at 35°C. After thorough washing, they were stained for 1 h at 
35°C  with  100-fold  diluted  FITC-labeled  anti-rabbit  goat  IgG  or 
rhodamine-labeled anti-mouse goat IgG in 5% skim milk,  and 10% nor- 
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normal rabbit  IgG  or normal mouse IgG  as the first antibodies.  After 
washing, cells were mounted and observed with a microscope (Axiophoto; 
Zeiss, Inc., Thornwood, NY). In the phosphatase treatment study, cells 
were incubated with 20 U/ml calf intestine alkafine phosphatase (TOYOBO, 
Tokyo, Japan) in alkali phosphatase buffer (50 mM Tris, pH 8.0) at 37°C 
for 2 h (Papasozomenos and Binder, 1987; Kanai et al., 1989). After wash- 
ing with PBS, the cells were stained as described above. 
For Western blotting, MT proteins were purified from cultured spinal 
cord cells (N3-wk culture) by the taxol-dependent procedure described by 
Vallee (1982). The cells were scraped from culture dishes after washing 
with PBS and then homogenized in 1.5  vol of PEM.  The homogenates 
were centrifuged at 180,000 g for 90 rain at 4°C, the supernatant was col- 
lected, and GTP and taxol were added (final 1 mM GTP, 20 mM taxol). 
This was followed by warming the supernatant at 37°C for 15 min to allow 
MT polymerization, after which they were centrifuged at 100,000 g for 40 
rain at 30°C. The resultant pellets (MT proteins) were separated by SDS- 
PAGE and transferred onto nitrocellulose sheets. The sheets were immu- 
noblotted  using anti-MAP2 mAb  (HM2;  Sigma Chemical Co.),  which 
stains MAP2A, B, C, and anti-tau mAb (tau-1; Boehringer Mannheim 
Biochemicals, Indianapolis, IN),  followed by 125I goat anti-mouse IgG 
(ICN Pharmaceuticals, Inc., Irvine, CA). 
Immunofluorescence Localization of Biotin-MAPs 
Cells were fixed with 0.3% glutaraldehyde in a  PEM buffer for 20 rain, 
washed with PBS, treated with 1 mg/ml NaBH4 in PBS for 30 min, and 
permeabilized with 1% Triton X-100 in PBS for 30 min at RT. The cells 
were sequentially incubated with 5% skim milk in PBS for 30 min at RT 
and then again with 100-times diluted rabbit antibiotin (Enzo Biochem., 
Inc., New York, NY) in 5% skim milk in PBS for 1 h at RT. After thor- 
ough washing, they were again sequentially incubated with 5% skim milk 
in PBS for 30 min at RT, followed by incubation with 100-fimes diluted 
rhodamine-conjugated goat anti-rabbit IgG  (Cappel Laboratories, Coch- 
aranville, PA) in 5% skim milk in PBS for 1 h  at RT. For some biotin- 
MAP2-injected cells, the cells were double stained with anti-biotin rabbit 
IgG and anti-MAP2 mouse mAbs (Sato et al., 1989)  as first antibodies, 
and  rhodamine-conjugated goat  anti-rabbit  IgG  and  FITC-conjugated 
goat anti-mouse IgG as second antibodies. In other cases, injected cells 
were  permeabilized  with  a  solution  containing 30%  glycerol,  80  mM 
Pipes, pH 6.8, 10 mM MgCI2, 1 mM EGTA, 2.5 mM GTP, and 1% Triton 
X-100 for 2 min, and fixed with 5 mM ethylene glycol-bis-succinimidyl  suc- 
cinate (Gorbsky et al., 1987) in a PEM buffer plus 1 mM GTP and 10 mM 
taxol for 20 rain at 37°C.  The cells were washed several times with PBS 
and quenched with 100 mM glycine-PBS for 30 rain. After blocking with 
5% skim milk in PBS for 1 h, they were incubated with 100-times diluted 
anti-biotin rabbit IgG in 5% skim milk in PBS for 1 h. After washing with 
PBS they were again incubated with 5% skim milk in PBS for 30 min at 
35°C, followed by staining with 100-times diluted rhodamine-conjugated 
rabbit anti-goat IgG in 5% skim milk in PBS for 1 h at RT. For PC12 cells 
microinjected  with  biotin-MAP2C,  the cells were  treated  as  described 
above and stained with a mixture of anti-biotin rabbit IgG and anti-tuhu- 
lin mouse IgG as the first antibodies, and rhodamine-goat anti-rabbit IgG 
and fluorescein goat anti-mouse IgG  being used as second antibodies. 
Cells were  examined with  a  Zeiss Axiophoto fluorescence microscope. 
The  fluorescence micrographs of spinal cord  neurons were  taken  and 
printed under the same conditions. 
Electron Microscopy Immunocytochemistry 
Spinal cord neurons and PC12 cells were microinjected with biotin-MAP2, 
-MAP2C, or -tau and permeabilized as described above. The cells were 
subsequently fixed with 0.3%  glutaraldehyde in PEM buffer plus 1 mM 
GTP and 10 mM taxol for 30 min at RT and then processed for EM using 
anti-biotin antibodies and colloidal gold (5 nm)-labeled second antibodies 
(Janssen Pharmaceutica, Beerse, Belgium) according to Okabe and Hi- 
rokawa (1989). 
Immunoblotting and Quantitation of MAP2 in 
Peripheral Nerve Axons 
MT protein was purified from mouse sciatic nerves by the taxol-depen- 
dent procedure described by Vallee (1982). Briefly, sciatic nerves from 30 
mice were homogenized in 1.5 vol of PEM buffer (100 mM PMSF, 1 mg/ 
ml leupeptin) and centrifuged at 180,000 g for 90 rain at 4°C. The superna- 
tant at this stage is referred to as cytosolic extract. Taxol was added to 20 
mM and GTP to 1 mM, the solution was warmed to 37°C for 30 min, and 
an MT pellet was formed by centrifuging at 100,000 g for 40 min at 30°C. 
For the quantitation of MAP2 and tubulin, MT protein was separated by 
SDS-PAGE and then transferred onto nitrocellulose sheets. Purified tu- 
bulin and MAP2 from porcine brain were loaded onto the same sheets as 
the concentration standards. The sheets were immunoblotted using anti- 
MAP2 polyclonal antibody (Hirokawa et al., 1988b) followed by 1251 pro- 
tein A (ICN Pharmaceuticals, Inc.) or anti-ct-tubulin mAb (DMIA; Sigma 
Chemical Co.), followed by lzsI goat anti-mouse IgG (ICN Pharmaceuti- 
cals, Inc.). The quantitation of protein concentration was performed using 
an image analyzer (Bas 2000;  Fuji Photo Film Co., Ltd., Tokyo, Japan). 
Immunoblotting of MAPs in sciatic nerve cytosolic extract was similarly 
performed. For  the first antibodies, we used anti-MAP1A mAb (Shio- 
mura and  Hirokawa,  1987a),  anti-MAP2 mAb (HM2;  Sigma Chemical 
Co.) and anti-tau mAb (tau 1; Boehringer Mannheim Biochemicals). 
Axon  Measurements 
To measure the length of the axon where the biotin-MAPs had been con- 
veyed after 24 h, micrographs were printed at a magnification of 213, and 
the length of the fluorescent axon from the leading edge of detectable flu- 
orescence showing higher fluorescence than the background staining of 
axons of uninjected neurons to the cell body was measured. 
Results 
Biotinylated MAPs Bound to MTs In Vitro and In Vivo 
To examine whether biotinylated tau, MAP2, or MAP2C 
binds to tubulin, we incubated native tau, native MAP2, 
native MAP2C, biotin-tau, -MAP2, or -MAP2C with phos- 
phocellulose column-purified tubulin in PEM buffer con- 
taining 1 mM GTP. After incubation at 37°C for 30 min, 
the samples were centrifuged at 107,000 g at 35°C for 30 
min. Fig. 2 A shows SDS gel electrophoresis patterns of bi- 
otinylated tau (Fig. 2, lane 1), biotinylated MAP2 (Fig. 2, 
lane 4), and biotinylated MAP2C (Fig. 2, lane 7); superna- 
tants and pellets of native tau plus tubulin (Fig. 2, lane 2), 
biotinylated tau plus tubulin (Fig. 2, lane 3), supernatants 
and pellets of native MAP2 plus tubulin (Fig. 2, lane 5), 
and biotinylated MAP2 plus tubulin (Fig. 2, lane 6); and 
supernatants  and  pellets  of native  MAP2C  plus  tubulin 
(Fig. 2, lane 8) and biotinylated MAP2C plus tubulin (Fig. 2, 
lane 9). Note that biotin-tau, -MAP2, and -MAP2C (Fig. 2, 
lanes 3, 6, and 9) effectively bound to tubulin. When we 
microinjected biotin-tau, -MAP2,  or -MAP2C into PC12 
cells to determine if these proteins bound to MTs in vivo, 
it was found that they (Fig. 2, B, C, and D, respectively) 
bound  to MTs  that  were  permeabilized before fixation. 
These data indicate that biotin-tau, -MAP2, and -MAP2C 
are capable of effectively binding to tubulin both in vitro 
and in vivo. 
Cultured Spinal Cord Neurons Develop Polarized 
Distribution of Tau, MAP2, and MAP2C 
First  we  confirmed whether  the  cultured  mature  spinal 
cord neurons (~3 wk) compartmentalize native tau mainly 
to  axons  and  MAP2  and  MAP2C  to dendrites.  Double 
staining with anti-tau antibodies and anti-MAP2 antibodies 
indicates that  anti-tau  antibodies  (Tau-1) mainly stained 
axons, whereas anti-MAP2 antibodies specifically stained 
dendrites. In addition, these antibodies can only stain neu- 
rons. Because tau-1 does not recognize tau proteins phos- 
phorylated at tau-1 site, and because it was suggested that 
tau proteins phosphorylated at tau-1  site exist in certain 
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Figure 1.  Possible  mechanisms for the compartmentalization of 
MAP2, MAP2C, and tau based on previous studies  and subjects 
of the present study. 
amounts in dendrites and in cell bodies in vivo (Papasozo- 
menos and Binder,  1987), we stained the spinal cord neu- 
rons  with  tau-1  antibodies  after  treatment  with  alkaline 
phosphatase  (Papasozomenos  and  Binder,  1987).  Tau-1 
stained many axons and some dendrites and cell bodies. In 
terms  of the dendritic staining,  double staining with anti- 
MAP2 antibodies revealed that tau-1 staining tended to be 
restricted  to  cell  bodies  and  some  proximal  dendrites, 
while  many  dendrites  were  not  stained.  Thus,  our  data 
demonstrate  that mature spinal cord neurons localize tau 
abundantly in axons, whereas cell bodies and some proxi- 
mal dendrites  localize tau phosphorylated at tau-1  site in 
small amounts.  Concerning the localization of MAP2 and 
MAP2C, it should be realized that antibodies that specifi- 
cally stain  MAP2C  are  not  available.  However,  because 
anti-MAP2  antibodies  that  recognize  MAP2A,  MAP2B, 
and MAP2C (HM-2; Sigma Chemical Co.) stain only cell 
bodies and dendrites, MAP2C is not localized immunoflu- 
orescently in the axon of spinal cord neurons at this stage. 
Immunoblotting of MT proteins from spinal cord--cultured 
Figure 2.  (A)  SDS-PAGE analysis  of biotinylated tau,  MAP2, 
and MAP2C stained with Coomassie brilliant  blue. (Lane 1) Bi- 
otinylated tau; (lane 2) supernatant (S) and pellet (P) of tau plus 
tubulin; (lane 3) supernatant (S) and pellet (P) of biotinylated tau 
plus  tubulin;  (lane 4)  biotinylated MAP2; (lane 5) supernatant 
(S) and pellet (P) of MAP2 plus tubulin; (lane 6) supernatant (S) 
and pellet (P) of biotinylated MAP2 plus tubulin; (lane  7) bio- 
tinylated  MAP2C;  (lane  8)  supernatant  (S)  and  pellet  (P)  of 
MAP2C plus tubulin; (lane 9) supernatant  (S) and pellet (P) of 
biotinylated  MAP2C  plus  tubulin.  Note  that  biotinylated  tau, 
MAP2, and MAP2C efficiently bind to tubulin.  Electron micro- 
graphs (B-D) of PC12 cells that were permeabilized, fixed,  and 
stained with anti-biotin antibodies and colloidal gold-labeled sec- 
ond antibodies after microinjection of biotin-tau (B), -MAP2 (C), 
or -MAP2C (D). Note that injected tau, MAP2, and MAP2C effi- 
ciently bind to microtubules.  B-D  are the same magnification. 
Bar, 200 nm. 
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(data not shown). These data, in conjunction with immu- 
nofluorescence microscopy results,  confirm the  evidence 
that mature spinal  cord neurons localize MAP2C in cell 
bodies and in dendrites. 
Microinjection of Biotin-labeled UPs  into 
Mature Spinal Cord Neurons in Culture and Analysis 
of Their Fates and MT Binding 
Equal  amounts of biotinylated tau,  MAP2, and MAP2C 
were  separately microinjected into primary-cultured ma- 
ture spinal cord neurons, with the microinjected cells then 
being fixed after specific time periods and processed for 
immunofluorescent microscopy using anti-biotin first anti- 
bodies and rhodamine-labeled second antibodies. 24 h af- 
ter the injection, tau, MAP2, and MAP2C were found in 
both axons and dendrites in 100%  of the cells examined 
(Tau,  95 cells;  MAP2, 92 cells;  MAP2C, 107 cells).  Tau, 
MAP2,  and  MAP2C  in  the  axon  moved  progressively, 
traveling 2.30 _+ 0.85 mm (n  =  22), 1.58  _  0.49 mm (n  = 
30), and 1.7 -- 0.42 mm (n =  10), respectively, away from 
cell  bodies  after 24 h.  Since  biotin-MAP2 was  detected 
with anti-biotin antibodies in axons that normally are not 
stained  with  anti-MAP2  antibodies,  the  question  arises 
whether anti-biotin staining really reflects the localization 
of labeled MAP2. To clarify this, we double stained  the 
microinjected  neurons  with  anti-biotin  antibodies  and 
anti-MAP2 antibodies. MAP2 was detected in the axons of 
a microinjected neuron. 
Next, we examined the affinity of injected tau, MAP2, 
and MAP2C for microtubules in axons and dendrites. To 
do this, 4 h after the injection, the cells were permeabilized 
with  1%  Triton X-100 in MT-stabilized buffer, and then 
fixed and processed for anti-biotin staining. This method 
enabled  us  to extract  soluble  proteins  and  observe only 
tau, MAP2, and MAP2C that bind to the cytoskeleton. In- 
terestingly, although tau was found in both axons and den- 
drites (Fig. 3 A), MAP2 tended to be confined to dendrites 
and cell bodies (Fig. 3 B). MAP2C also tended to be local- 
ized in dendrites and cell bodies (Fig. 3 C). This pattern of 
localization of MAP2 and MAP2C did not change at 24 h 
after injection. However, in the case of tau, the staining in 
dendrites and cell bodies became weak, while persisting in 
the axons (Fig. 4). As shown, all three are intensely bound 
to the neuronal cytoskeleton. At the EM level, we found 
that the gold particles were scattered in the cytoplasm of 
axons and dendrites in nonpermeabilized cells (Fig. 5 A). 
Figure 3.  Immunofluorescence 
localization  of biotin-tau  (A), 
-MAP2  (B),  and  -MAP2C  in 
spinal cord neurons  that  were 
permeabilized  and  then  fixed. 
(A)  Anti-biotin  staining  of a 
cell  permeabilized  and  fixed 
4  h  after  injecting biotin-tau. 
Labeled tau exists in the axon 
(short arrows) and  dendrites 
(long arrows). (B) Anti-biotin 
staining of a cell permeabilized 
and fixed 4 h after injecting bi- 
otin-MAP2.  Labeled  MAP2 
exists in the dendrites (long ar- 
rows), but  is  not  detected  in 
the axon. (C) Anti-biotin stain- 
ing of cells permeabilized  and 
fixed 4 h after injecting biotin- 
MAP2C.  Labeled  MAP2C  is 
only  detected  in  dendrites. 
Bars, 100 ram. 
Hirokawa et al, Differential Turnover  of Tau and MAPC  671 Figure 4.  (A) Immunofluorescence localization of biotin-tau in a spinal cord neuron that was permeabilized and fixed 24 h after inject- 
ing biotin-tau. Labeled tau is detected clearly in the axon (arrow) for a long distance, whereas staining in dendrites is much weaker (ar- 
rowhead) and in some dendrites staining is not detected (B, thin arrows). (B) The DIC image of the same field as A. Bar, 100 mm. 
However, in permeabilized cells, tau, MAP2, and MAP2C 
were mainly localized in MT domains, and gold particles 
were especially observed between or on MTs in these per- 
meabilized cells (Figs. 5, B-C and 6 A), while in the axon 
of cells injected with MAP2 only a few gold particles were 
found in MT domains (Fig. 6 B). This pattern of localiza- 
tion  of gold particles  resembles  that  of the  immunocy- 
tochemical localization of MAPs detected with gold-labeled 
second antibodies in permeabilized neurons in vivo (Shio- 
mura and Hirokawa, 1987a, b; and Hirokawa et al., 1988b). 
3 d  after injecting the cells fixed without permeabiliza- 
tion, the localization of injected tau, MAP2, and MAP2C 
in  the  axons  was  notably  different.  Although  MAP2 
tended to vanish in axons or was detectable only in their 
proximal region (i.e., 19% of the cells examined in axons, 
cell bodies, and dendrites, but 81% in the cell bodies and 
dendrites) (Fig. 7 B), the presence of tau persisted for a 
considerable length in axons, namely, 53% in axons, cell 
bodies,  and  dendrites,  and  47%  in  axons  (Fig.  7 A).  In 
contrast,  MAP2C  was  localized in  cell bodies  and  den- 
drites at 50%, and in axons, cell bodies, and dendrites at 
50% (Fig. 7 C). 
4 d  after the injection, however, tau had almost disap- 
peared from cell bodies and dendrites, though it persisted 
in axons to a remarkable length: 94% in axons, and 6% in 
axons, cell bodies, and dendrites (Fig. 8 A). In fact, at this 
stage we still found MAP2 at 80% in cell bodies and den- 
drites,  and  at  20%  in  axons,  cell bodies,  and  dendrites 
(Fig. 8 B), although its staining tended to be weaker than 
at day 3 of postinjection. At this stage the injected MAP2C 
was  localized in the axons, cell bodies, and dendrites at 
33%, while it was found at 67%  in cell bodies and den- 
drites (Fig. 8  C). The localization of biotin -tau, -MAP2, 
and  -MAP2C  in  nonpermeabilized  cells  at  several time 
points is summarized in Fig. 9. 
Existence of MAP2 in Peripheral Nerve Detected by 
Immunoblotting In Vivo 
Whether or not MAP2 exists in axons in vivo remains a 
controversy. Although several immunofluorescence stud- 
ies did not detect MAP2 in axons (Bernhardt and Matus, 
1984; Cumming et al., 1984; Caceres et al., 1984; De Cam- 
illi  et  al.,  1984), Vallee  (1982)  reported its  existence in 
white matter by a  biochemical study. Other immunohis- 
tochemical studies also indicated that MAP2 is localized in 
the axons of peripheral nerves, although only in limited 
quantities  (Papasozomcnos et al.,  1985;  Hirokawa et al., 
~.~,~.  ~  ~.  .  . 
1985).  Thus, to determm~ffMAP2 really exasts m axons, 
we  used  immunoblotting  of homogenates  of peripheral 
nerves by anti-MAP2  antibodies. Anti-MAP2  antibodies 
clearly stained  a  band  of ~280  kD,  thus  supporting the 
possibility  that  a  small  amount  of  MAP2  is  actually 
present in these nerves in vivo (Fig. 10). For comparison, 
the same materials were immunoblotted using anti-MAP1A 
antibodies, anti-tau antibodies, and anti-tubulin antibodies 
The Journal  of Cell Biology, Volume  132, 1996  672 Figure 5.  Electron micrographs of neurons fixed and then permeabilized (A) or permeabilized and then fixed (B and C) 4 h after micro- 
injection of biotin-tau. A shows a varicosity in an axon. Gold particles are scattered in the cytoplasm. B and C show axons in a permeabi- 
lized cell, where gold particles tend to be localized either between or on the microtubules,  though they are not localized in the neurofil- 
ament domains (*). Bar, 100 nm. 
(Fig.  10).  As another experiment to quantify the amount 
of MAP2 in sciatic nerves relative to tubulin, we immuno- 
blotted MT pellets, purified MAP2 and tubulin using anti- 
MAP2  and  anti-tubulin  antibodies,  and  then quantitated 
the amount to have a 1:200 weight ratio of MAP2 to tubulin. 
Discussion 
Cultured Spinal Cord Neurons 
Develop Compartmentalization  of Tau, MAP2, 
and MAP2C 
Cultured spinal cord neurons (N3 wk) revealed a charac- 
teristic staining pattern with the tau-1  antibody and anti- 
MAP2 antibodies similar to that for nerve cells in vivo and 
other  mature  neurons  in  vitro;  namely,  tau-1  stains  the 
axon, while anti-MAP2 stains dendrites. In terms of tau lo- 
calization,  Papasozomenos  and  Binder  (1987)  suggested 
that tau protein phosphorylated at the tau-1 site also exists 
in some dendrites.  Other studies, however, showed com- 
partmentalized localization of tau in the axon with anti-tau 
polyclonal antibodies (Kosik and Finch, 1987; Brion et al., 
1988), and recently it was shown that although differently 
phosphorylated tau exists in dendrites in developing neu- 
rons, it tends to be compartmentalized in the axon and cell 
body in mature neurons  (>2 wk in culture)  (Mandel  and 
Banker,  1995).  In fact,  our immunofluorescence  data  of 
spinal cord neurons treated with alkaline-phosphatase also 
indicated that in our system tau is mainly compartmental- 
ized in the axon, although tau proteins phosphorylated at 
tau-1 site are also localized in small amounts in some prox- 
imal dendrites and cell bodies. 
Concerning the localization of MAP2C in juvenile neu- 
rons, it has been proven by two approaches to be localized 
in  axons:  (i)  immunofluorescence  microscopy using  one 
antibody which stains both MAP2A/2B and MAP2C, and 
another antibody which stains only MAP2A/2B (Tucker et 
al., 1988a), and (ii) transfection of tagged MAP2C eDNA 
into  cultured  neurons  (Meichsner  et  al.,  1993).  On  the 
other  hand,  Tucker  et  al.  (1988b)  showed  that  MAP2C 
Hirokawa et al. Differential Turnover of Tau and MAPC  673 Figure 6.  Electron micrographs of a neuron permeabilized and then fixed 4 h after microinjection of biotin-MAP2. A shows a dendrite. 
Gold particles are localized between or on the microtubules in the dendritic microtubule domain. B shows the axon of the same cell 
shown in A. *, neurofilament domains characteristic in the axon. Only a few gold particles are observed in the axon. Bar, 100 nm. 
was not localized immunofluorescently in the axon of ma- 
ture neurons,  and we too did not detect it in the axon of 
cultured spinal cord neurons.  However, because our im- 
munoblotting study indicated the existence of MAP2C in 
cultured spinal cord cells, and because only cell bodies and 
dendrites of neurons were stained with antibodies that rec- 
ognize MAP2A/2B  and MAP2C,  it is reasonable to con- 
clude that cultured mature  spinal cord neurons  compart- 
mentalize  MAP2C  in  cell  bodies  and  dendrites.  Thus, 
judging  from  the  characteristic  staining  pattern  we  ob- 
tained using anti-tau and anti-MAP2 antibodies, we con- 
sider our cultured spinal cord neurons as a  model system 
of mature neurons. 
Biotin-labeled MAPs Progressively Moved in the 
Axon at a Slow Transport Rate 
After biotinylation, tau,  MAP2,  and  MAP2C  effectively 
bound to MTs both in vitro and in vivo. In addition, dou- 
ble staining with anti-biotin antibody and anti-MAP2 anti- 
body showed that labeled MAP2 is conveyed in the axon. 
Although there may be some technical limitation in deter- 
mining the  rate  of axonal  transport  of cytoskeletal pro- 
teins by the microinjection method, our data (tau, MAP2, 
and MAP2C moved 2.30 _+ 0.85 mm, 1.58 +- 0.49 ram, and 
1.7 -+ 0.42 ram, respectively, in 24 h) indicate that the rates 
for the biotin-labeled proteins are in the range of slow ax- 
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1984).  In this regard, Nixon et al. (1990) recently showed 
that MAP1A  is transported in the axon of mouse  retinal 
ganglion cells at  a  rate  of 1.0-1.2  mm/d.  Because the  la- 
beled MAPs  reached  >1  mm  in  the  axon  from  the  cell 
Figure  7.  Immunofluorescence 
localization of biotinylated tau 
(A),  biotinylated MAP2  (B), 
and  biotinylated MAP2C  (C) 
in spinal cord neurons fixed 3 d 
after  microinjection. (A)  Tau 
exists  in  the  axon  and  den- 
drites  (arrows).  Although  tau 
is detected clearly for long dis- 
tance  in  the  axon,  dendritic 
staining is weak (arrows). Bar, 
100 mm. (B) MAP2 persists in 
the  cell  body  and  dendrites 
(long arrows), but is localized 
only in the proximal region of 
the  axon  (short  arrows).  (C) 
MAP2C also persists in the cell 
body  and  dendrites,  although 
in  a  much  shorter  proximal 
segment in the axon compared 
to that of tau. Bar, 100 mm. 
body, and judging from the rates for the transport of la- 
beled MAPs, the movement  of these MAPs could not be 
explained by simple diffusion (Lasek,  1988;  Sabry et  al., 
1995).  Taken  together,  these  results  suggest  that  biotin- 
tau,  -MAP2,  and  -MAP2C  behave  normally in  injected 
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localization of biotin-tau (A), 
-MAP2 (B), and -MAP2C (C) 
in neurons fixed 4 d  after mi- 
croinjection.  (A) Tau still  ex- 
ists over a long distance along 
the axon. Since cell bodies and 
dendrites are not stained, only 
axons are recognizable by fluo- 
rescence microscopy. (B) MAP2 
still exists in the cell body and 
dendrites,  but vanishes in the 
axon. (C) MAP2C again exists 
in the cell body and dendrites, 
whereas  it  tends  to  vanish  in 
the axon. Bars, 100 mm. 
nerve cells and are transported down the axon. However, 
in  contrast,  our recent  transfection  studies  of cDNAs of 
tagged MAPs (tau, MAP2, MAP2C) into cultured mature 
spinal  cord  neurons  revealed  that,  although  tau  and 
MAP2C  are  detected  in  the  axons  over a  long distance 
from the  cell  body, MAP2  is  only localized  at  the  short 
proximal segment of axons (Kanai  and Hirokawa,  1995). 
Obviously then,  our  transfection  study suggests  the  sup- 
pression of the transit of MAP2 into axons, which is seem- 
ingly in contradiction  with  the  results  we previously ob- 
tained  after  microinjection  of biotin-MAP2  (Okabe  and 
Hirokawa,  1989) as well as the present results.  Neverthe- 
less, because previous studies have revealed the existence 
of MAP2 in axons in vivo immunocytochemically (Papaso- 
zomenos et al.,  1985; Hirokawa et al.,  1985)  and in white 
matter of brains biochemically (Vallee, 1982), and because 
our present  Western  blotting  data  for peripheral  nerves 
convincingly proved that  MAP2  exists  in  them,  albeit  in 
...............  we suggest that a small amount of MAP2 
is probably transported  down the axon in native neurons 
but is unstable so as to become undetectable more distally 
in the axon. 
Differential Affinity of Tau, MAP2, and MAP2C with 
MTs in the Axon vs Dendrites 
Our  results  also  indicate  that  microinjected  tau,  MAP2, 
and MAP2C have two different forms in the neuronal cy- 
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Figure 9,  Relative population of neurons which localize biotin- 
tau, -MAP2, and -MAP2C in particular regions of neurons at var- 
ious days after microinjection. The neurons are fixed and then 
permeabilized at certain time periods after microinjection of la- 
beled proteins. Percentages refer to percentage of cells with the 
indicated fluorescence distribution and are based on a total area 
of fluorescence above background. (Dendrite, Cell body & Axon ) 
The injected proteins are detected in dendrites, cell bodies, and 
axons. The injected proteins are localized along axons for a much 
longer distance than dendrites. (Axon) The injected proteins are 
only detected in axons. Neurons localize injected proteins in ax- 
ons at a longer distance than dendrites. (Dendrite & Cell body) 
The injected proteins are detected in dendrites and cell bodies. 
Neurons localizing injected proteins in axons at the same or a 
shorter distance from the cell body in comparison with dendrites 
are also included. 
toplasm,  MT-nonbound  and  MT-bound  forms.  Because 
phosphorylation is known to critically control the binding 
of MAPs to MTs, the balance between phosphatases and 
kinases controls which form occurs. The kinase candidates 
localized in neurons  that  phosphorylate these MAPs  are 
proline-directed  kinases  such  as  MAP  kinase,  glycogen 
Figure t0.  Immunoblot anal- 
ysis of mouse  sciatic nerves 
by anti-MAPs and anti-tubu- 
lin antibodies. The  cytosolic 
extract  from  mouse  sciatic 
nerves  was  separated  by 
SDS-PAGE  (7.5%  running 
gel), transferred onto a nitro- 
cellulose sheet, and immuno- 
blotted  using  anti-MAP1A 
mAb  (lane  1),  anti-MAP2 
mAb (lane 2), anti-tau mAb 
(lane  3),  anti-alpha  tubulin 
mAb (lane 4), and normal se- 
rum (lane 5). Molecular size 
standards (left). 
Microinjection  of biotin  tau 
~k  1  day 
1  ; 
"--M  L 
Microinjection  of biotin  MAP2c 
1  day 
w  ; 
(~  4 day 
Microinjection  of biotin  MAP2 
1  day 
4  day 
Figure 11.  Schematic drawing of the fates of microinjected tau, 
MAP2C, and MAP2 based on the present and previous studies 
(Okabe and Hirokawa, 1989). These results clearly indicated dif- 
ferential turnover and selective stabilization of tau, MAP2C, and 
MAP2. 
synthase kinase 3, or members of the cyclin-dependent ki- 
nase family, and other kinases such  as protein kinase A, 
protein kinase C, and Ca  2+ calmodulin kinase II. By com- 
paring the  localization of injected MAPs  in  dendrites of 
permeabilized cells to that in axons, we found that biotin- 
tau  binds  to  MTs  in  the  axon  and  dendrites,  whereas 
MAP2  and MAP2C  tend to more firmly bind to MTs  in 
dendrites and cell bodies in comparison with MTs  in the 
axon 4  h  after microinjection. However, 24 h  after micro- 
injection, the  affinity  of biotin-tau  to  MTs  in  dendrites 
tends to become much weaker than in the axon. Although 
we purified biotin-labeled MAPs  by MT binding so that 
they  would  undergo  this  activity  before  the  injection, 
there was  a  tendency for biotin-MAP2 and  -MAP2C to 
have weak affinity for MTs in the axon 4  h  after microin- 
jection. In the case of tau, although it took more time, bi- 
otin-tau in dendrites inclined to lose its affinity for MTs 24 h 
after microinjection. Such phenomena  may be caused by 
(a)  the  difference between  MTs  in  the  axon  vs  those  in 
dendrites, (b) the differential phosphorylation of MAPs in 
the axon vs that in dendrites, or (c) the differential sorting 
of distinct isoforms of MAPs, especially tau, in the axon vs 
that in dendrites. Concerning (a), the expression of differ- 
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might be related. Joshi and Cleveland (1989) revealed that 
isotype V is partially excluded from neurites of PC12 cells 
differentiated by NGF. However, until now, no evidence 
has been available to suggest that the 13 tubulin isotype is 
different between MTs in axons and dendrites. This is also 
the case for (c), as there is no evidence to indicate that cer- 
tain  isoforms  of  tau  are  preferentially  localized  in  the 
axon.  Therefore,  the  distinct  MT-binding  activity  of in- 
jected MAPs in the axon vs. that in the cell body and den- 
drites could be mainly controlled by the phosphorylation 
of  MAPs.  Because  microinjected  MAPs  were  derived 
from  whole  brains,  they  contain  several  differentially 
phosphorylated forms (Matsuo et al., 1994). Therefore, the 
time difference for the injected MAPs to acquire the ability 
of MT binding related to their selective location in certain 
compartments of neurons may be caused by the degree of 
the presence of several distinctly phosphorylated forms in 
the injected  MAPs.  The MT-binding activity of microin- 
jected MAP2 and MAP2C in spinal cord neurons basically 
revealed a similar tendency, and consequently, the critical 
sites  for phosphorylation  of MAP2  and  MAP2C,  which 
regulate  microtubule  binding,  could  reside  in  common 
MAP2C structures, namely in the short NH~-terminal re- 
gion,  and most probably in  the  MT-binding,  poline-rich, 
and  repeat  regions  at  the  COOH-terminus.  Concerning 
the control of MT-binding activity of MAPs, phosphoryla- 
tion of MAP2 and tau with kinases such as protein kinase 
A, Ca  2÷ calmodulin kinase II, MAP kinase (reviewed by 
Wiche  et  al.,  1991;  Drewes  et  al.,  1992;  Goedert  et  al., 
1992b), glucose synthase kinase 3 (Mandelkow and Man- 
delkow, 1995), CDK5 (Bauman et al., 1993; Kobayashi et 
al., 1993;  Paudel et al.,  1993),  CDC2  kinase (Ledesma et 
al., 1992),  and proline-directed kinase (Vulliet et al., 1992) 
induced  dissociation of MAPs from MTs, whereas in an- 
other case, phosphorylation in vivo by unknown  kinases 
induced  microtubule  binding  (Brugg  and  Matus,  1991). 
There is absolutely no argument that the overall process of 
the regulation of MT binding of MAPs by kinases is very 
complex indeed,  and  that  extensive research  will  be re- 
quired for its eventual clarification. 
Multiple Sorting Mechanisms of Tau and 
MAP2 in Neurons 
Concerning the  other possible mechanisms for the  com- 
partmentalization of MAPs, our previous study using the 
transfection of cDNAs of tau, MAP2, MAP2C, and their 
various deletion mutants into primary-cultured spinal cord 
neurons, the same system as the one used in the present 
study, indicated that transit of MAP2 into the axon was in- 
hibited, while tau and MAP2C were transported for a long 
distance  in  the  axon  (Kanai  and  Hirokawa,  1995).  This 
study clearly showed that the suppression of MAP2 transit 
into the axon plays an important role, whereas it also sug- 
gests that mere suppression of the transit of MAPs is not 
enough to determine their selective localization as MAP2C 
is restricted to localization in dendrites and cell bodies de- 
spite its transit into the axon for a  long distance. On the 
other  hand,  the  differential  localization  of mRNA  may 
work  for MAP2  and  tau  as  another  mechanism for the 
compartmentalization of MAPs  (Garner et al., 1988;  Lit- 
man et al., 1993). However, in the case of MAP2C, a previ- 
ous  study by Garner et  al.  (1988)  showed  that  MAP2C 
mRNA is confined to the cell body in a different manner 
from  MAP2  mRNA,  which  is  extended  into  dendrites, 
whereas  MAP2C  is  compartmentalized  in  the  cell  body 
and dendrites  in mature spinal cord neurons similarly to 
MAP2. Obviously, localization of MAP2C mRNA in itself 
cannot explain this final localization of MAP2C. This also 
highlights the differential turnover of MAP2C  as an im- 
portant mechanism for its final compartmentalization. 
Based  on the present study and previous studies,  it is 
reasonable to conclude that multiple mechanisms exist that 
cause  the  selective  localization  of tau  in  the  axon  and 
MAP2  and  MAP2C  in  dendrites  in  mature  neurons  in 
vivo. Some of these mechanisms are as follows: (a) the ex- 
tended localization of mRNA of MAP2 in dendrites (Gar- 
ner et al., 1988) and mRNA of tau in the initial segment of 
the axon (Litman et al., 1993), (b) the differential turnover 
and  selective  stabilization  of  tau,  MAP2,  and  MAP2C 
(Okabe and Hirokawa, 1989,  and present study), and (c) 
the decreased transit of MAP2 into axons (Kanai and Hi- 
rokawa, 1995).  Mechanisms (a-c) probably work in con- 
cert and lead to the final characteristic compartmentaliza- 
tion of tau, MAP2, and MAP2C in mature neurons. 
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